Nontuberculous mycobacteria in patients with cystic fibrosis

Seminars in Respiratory and Critical Care Medicine

Volumn 34, Issue 1, 2013, Pages 124-134

  Leung, Janice M ^a   Olivier, Kenneth N ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

cystic fibrosis; Mycobacterium abscessus; Mycobacterium avium complex; mycobacterium infections; nontuberculous mycobacteria

Indexed keywords

AMIKACIN; AZITHROMYCIN; CEFOXITIN; CLARITHROMYCIN; ETHAMBUTOL; IMIPENEM; IMMUNOGLOBULIN G; ISONIAZID; LINEZOLID; PYRIDOXINE; RIFAMPICIN; TIGECYCLINE;

ALGORITHM; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL GROWTH; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DIARRHEA; DISEASE COURSE; FORCED EXPIRATORY VOLUME; GENE SEQUENCE; HEPATITIS; HUMAN; HYPERSENSITIVITY; HYPERTRANSAMINASEMIA; LEUKOPENIA; LIVER TOXICITY; LUNG FUNCTION; LUNG TRANSPLANTATION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OPTIC NERVE DISEASE; OPTIC NEURITIS; OTOTOXICITY; PANCREATITIS; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SEIZURE; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; THROMBOCYTOPENIA; VOMITING;

ALGORITHMS; ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; DISEASE PROGRESSION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA;

EID: 84874397430     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1333574     Document Type: Article

References (130)

1. Hamosh A., FitzSimmons S. C., Macek M. Jr, Knowles M. R., Rosenstein B. J., Cutting G. R. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr: 1998; 132 2 255 259 (Pubitemid 28125176)
2. Khan T. Z., Wagener J. S., Bost T., Martinez J., Accurso F. J., Riches D. W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med: 1995; 151 4 1075 1082
3. Muhlebach M. S., Stewart P. W., Leigh M. W., Noah T. L. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med: 1999; 160 1 186 191 (Pubitemid 29326086)
4. Balough K., McCubbin M., Weinberger M., Smits W., Ahrens R., Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol: 1995; 20 2 63 70
5. Mearns M. B., Hunt G. H., Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child: 1972; 47 256 902 907
6. Rosenfeld M., Gibson R. L., McNamara S., et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol: 2001; 32 5 356 366 (Pubitemid 33015652)
7. Cystic Fibrosis Foundation Patient Registry Annual Data Report: 2009
8. Razvi S., Quittell L., Sewall A., Quinton H., Marshall B., Saiman L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest: 2009; 136 6 1554 1560
9. Millar F. A., Simmonds N. J., Hodson M. E. Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005. J Cyst Fibros: 2009; 8 6 386 391
10. Li Z., Kosorok M. R., Farrell P. M., et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA: 2005; 293 5 581 588 (Pubitemid 40171240)
11. Reid D. W., Blizzard C. L., Shugg D. M., Flowers C., Cash C., Greville H. M. Changes in cystic fibrosis mortality in Australia, 1979-2005. Med J Aust: 2011; 195 7 392 395
12. George P. M., Banya W., Pareek N., et al. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ: 2011; 342 d1008
13. Boxerbaum B. Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. J Pediatr: 1980; 96 4 689 691 (Pubitemid 10110316)
14. Hjelte L., Petrini B., Källenius G., Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax: 1990; 45 5 397 400 (Pubitemid 20184900)
15. Kilby J. M., Gilligan P. H., Yankaskas J. R., Highsmith W. E. Jr, Edwards L. J., Knowles M. R. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest: 1992; 102 1 70 75
16. Aitken M. L., Burke W., McDonald G., Wallis C., Ramsey B., Nolan C. Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest: 1993; 103 4 1096 1099 (Pubitemid 23110278)
17. Cullen A. R., Cannon C. L., Mark E. J., Colin A. A. Mycobacterium abscessus infection in cystic fibrosis: colonization or infection? Am J RespirCrit Care Med: 2000; 161 2 Pt 1 641 645 (Pubitemid 30129479)
18. Rodman D. M., Polis J. M., Heltshe S. L., et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med: 2005; 171 6 621 626 (Pubitemid 40365418)
19. Olivier K. N., Weber D. J., Wallace R. J. Jr., et al. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med: 2003; 167 6 828 834 (Pubitemid 36801769)
20. Forslöw U., Geborek A., Hjelte L., Petrini B., Heurlin N. Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta Paediatr: 2003; 92 8 910 915 (Pubitemid 37088627)
21. Leitritz L., Griese M., Roggenkamp A., Geiger A. M., Fingerle V., Heesemann J. Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis. Med Microbiol Immunol (Berl): 2004; 193 4 209 217 (Pubitemid 40063686)
22. Esther C. R. Jr, Henry M. M., Molina P. L., Leigh M. W. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol: 2005; 40 1 39 44 (Pubitemid 40917906)
23. Girón R. M., Máiz L., Barrio I., Martínez M. T., Salcedo A., Prados C. Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study [in Spanish]. Arch Bronconeumol: 2008; 44 12 679 684
24. Sermet-Gaudelus I., Le Bourgeois M., Pierre-Audigier C., et al. Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis: 2003; 9 12 1587 1591 (Pubitemid 37505455)
25. Esther C. R. Jr, Esserman D. A., Gilligan P., Kerr A., Noone P. G. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros: 2010; 9 2 117 123
26. Roux A. L., Catherinot E., Ripoll F., et al. Jean-Louis Herrmann for the OMA Group Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol: 2009; 47 12 4124 4128
27. Pierre-Audigier C., Ferroni A., Sermet-Gaudelus I., et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol: 2005; 43 7 3467 3470 (Pubitemid 40981368)
28. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2010. www.cff.org/UploadedFiles/LivingWithCF/CareCenterNetwork/PatientRegistry/ 2010-Patient-Registry-Report.pdf
29. Torrens J. K., Dawkins P., Conway S. P., Moya E. Non-tuberculous mycobacteria in cystic fibrosis. Thorax: 1998; 53 3 182 185 (Pubitemid 28172368)
30. Smith M. J., Efthimiou J., Hodson M. E., Batten J. C. Mycobacterial isolations in young adults with cystic fibrosis. Thorax: 1984; 39 5 369 375 (Pubitemid 14140408)
31. Hjelt K., Hojlyng N., Howitz P., et al. The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis. Scand J Infect Dis: 1994; 26 5 569 576 (Pubitemid 24321302)
32. Fauroux B., Delaisi B., Clément A., et al. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J: 1997; 16 4 354 358 (Pubitemid 27172953)
33. Nick J. A. Nontuberculous mycobacteria in cystic fibrosis. Semin Respir Crit Care Med: 2003; 24 6 693 702 (Pubitemid 38036764)
34. Satyanarayana G., Heysell S. K., Scully K. W., Houpt E. R. Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infect Dis: 2011; 11 113
35. Levy I., Grisaru-Soen G., Lerner-Geva L., et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis: 2008; 14 3 378 384 (Pubitemid 351451383)
36. Falkinham J. O. III. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol: 2009; 107 2 356 367
37. Radhakrishnan D. K., Yau Y., Corey M., et al. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr Pulmonol: 2009; 44 11 1100 1106
38. Paugam A., Baixench M. T., Demazes-Dufeu N., et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol: 2010; 48 01 S32 S36
39. Mussaffi H., Rivlin J., Shalit I., Ephros M., Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J: 2005; 25 2 324 328 (Pubitemid 40246534)
40. Olivier K. N., Weber D. J., Lee J. H., et al. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group Nontuberculous mycobacteria, II: Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med: 2003; 167 6 835 840 (Pubitemid 36801770)
41. Renna M., Schaffner C., Brown K., et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest: 2011; 121 9 3554 3563
42. Griffith D. E., Aksamit T., Brown-Elliott B. A., et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med: 2007; 175 4 367 416 (dosage error corrected in Am J Respir Crit Care Med 2007;175(7):744-745)
43. Bange F. C., Brown B. A., Smaczny C., Wallace R. J. Jr, Böttger E. C. Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin Infect Dis: 2001; 32 11 1648 1650 (Pubitemid 32458737)
44. Saiman L., Siegel J. Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control: 2003; 31 3, Suppl S1 S62 (Pubitemid 36798093)
45. Aitken M. L., Limaye A., Pottinger P., et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med: 2012; 185 2 231 232
46. Whittier S., Hopfer R. L., Knowles M. R., Gilligan P. H. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol: 1993; 31 4 861 864 (Pubitemid 23086529)
47. Whittier S., Olivier K., Gilligan P., Knowles M., Della-Latta P. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. J Clin Microbiol: 1997; 35 10 2706 2708 (Pubitemid 27402696)
48. Bange F. C., Kirschner P., Böttger E. C. Recovery of mycobacteria from patients with cystic fibrosis. J Clin Microbiol: 1999; 37 11 3761 3763 (Pubitemid 29491136)
49. Ferroni A., Vu-Thien H., Lanotte P., et al. Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. J Clin Microbiol: 2006; 44 6 2237 2239 (Pubitemid 43902182)
50. Esther C. R. Jr, Hoberman S., Fine J., et al. Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis. J Clin Microbiol: 2011; 49 4 1421 1425
51. Oliver A., Maiz L., Cantón R., Escobar H., Baquero F., Gómez-Mampaso E. Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis: 2001; 32 9 1298 1303 (Pubitemid 32405901)
52. Kubica G. P., Dye W. E., Cohn M. L., Middlebrook G. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis: 1963; 87 775 779
53. Martin M. E., Horton C. L., Sheffner A. L., Solomon J. D. Direct comparison of the N-acetyl-l-cysteine-sodium hydroxide and the trisodium phosphate digestion methods for the culture of mycobacteria. Appl Microbiol: 1968; 16 3 506 508
54. Whittaker L. A., Teneback C. Atypical mycobacterial and fungal infections in cystic fibrosis. Semin Respir Crit Care Med: 2009; 30 5 539 546
55. Cystic Fibrosis Foundation Patient Registry Annual Data Report 1997. Bethesda, MD Cystic Fibrosis Foundation: 1997
56. Bange F. C., Böttger E. C. Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis: 2002; 21 7 546 548
57. Portaels F. Epidemiology of mycobacterial diseases. Clin Dermatol: 1995; 13 3 207 222
58. Thoen C. O., Himes E. M., Jarnagin J. L., Harrington R. Jr. Comparison of four culture media for isolation of Mycobacterium avium complex from porcine tissues. J Clin Microbiol: 1979; 9 2 194 196 (Pubitemid 9123782)
59. Peterson E. M., Lu R., Floyd C., Nakasone A., Friedly G., de la Maza L. M. Direct identification of Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium intracellulare from amplified primary cultures in BACTEC media using DNA probes. J Clin Microbiol: 1989; 27 7 1543 1547 (Pubitemid 19170160)
60. Idigoras P., Pérez-Trallero E., Alcorta M., Gutiérrez C., Muñoz-Baroja I. Rapid detection of tuberculous and non-tuberculous mycobacteria by microscopic observation of growth on Middlebrook 7H11 agar. Eur J Clin Microbiol Infect Dis: 1995; 14 1 6 10
61. Wilson M. L., Stone B. L., Hildred M. V., Reves R. R. Comparison of recovery rates for mycobacteria from BACTEC 12B vials, Middlebrook 7H11-selective 7H11 biplates, and Lowenstein Jensen slants in a public health mycobacteriology laboratory. J Clin Microbiol: 1995; 33 9 2516 2518
62. Ngan G. J., Ng L. M., Jureen R., Lin R. T., Teo J. W. Development of multiplex PCR assays based on the 16S-23S rRNA internal transcribed spacer for the detection of clinically relevant nontuberculous mycobacteria. Lett Appl Microbiol: 2011; 52 5 546 554
63. Leung K. L., Yip C. W., Cheung W. F., Lo A. C., Ko W. M., Kam K. M. Development of a simple and low-cost real-time PCR method for the identification of commonly encountered mycobacteria in a high throughput laboratory. J Appl Microbiol: 2009; 107 5 1433 1439
64. Devine M., Moore J. E., Xu J., et al. Detection of mycobacterial DNA from sputum of patients with cystic fibrosis. Ir J Med Sci: 2004; 173 2 96 98 (Pubitemid 39430077)
65. Mulherin D., Coffey M. J., Halloran D. O., Keogan M. T., FitzGerald M. X. Skin reactivity to atypical mycobacteria in cystic fibrosis. Respir Med: 1990; 84 4 273 276 (Pubitemid 20271043)
66. Cocito C. G. Properties of the mycobacterial antigen complex A60 and its applications to the diagnosis and prognosis of tuberculosis. Chest: 1991; 100 6 1687 1693
67. Caminero J. A., Rodriguez de Castro F., Carrillo T., Diaz F., Rodriguez Bermejo J. C., Cabrera P. Diagnosis of pleural tuberculosis by detection of specific IgG anti-antigen 60 in serum and pleural fluid. Respiration: 1993; 60 1 58 62 (Pubitemid 23117209)
68. Ferroni A., Sermet-Gaudelus I., Le Bourgeois M., et al. Measurement of immunoglobulin G against Mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus. Clin Infect Dis: 2005; 40 1 58 66 (Pubitemid 40053460)
69. Boxerbaum B. Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. J Pediatr: 1980; 96 4 689 691 (Pubitemid 10110316)
70. Tomashefski J. F. Jr, Stern R. C., Demko C. A., Doershuk C. F. Nontuberculous mycobacteria in cystic fibrosis: an autopsy study. Am J Respir Crit Care Med: 1996; 154 2 Pt 1 523 528 (Pubitemid 26269129)
71. Ebert D. L., Olivier K. N. Nontuberculous mycobacteria in the setting of cystic fibrosis. Clin Chest Med: 2002; 23 3 655 663
72. Hodson M. E. Bacterial infection in cystic fibrosis (CF): special reference to mycobacteria and Burkholderia cepacia. Pediatr Pulmonol Suppl: 1995; 11 66 67
73. Efthimiou J., Smith M. J., Hodson M. E., Batten J. C. Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis. Br J Dis Chest: 1984; 78 3 299 302 (Pubitemid 14122875)
74. Catherinot E., Roux A. L., Macheras E., et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol: 2009; 47 1 271 274
75. Razvi S., Saiman L. Nontuberculous mycobacteria in cystic fibrosis. Pediatr Infect Dis J: 2007; 26 3 263 264 (Pubitemid 46340777)
76. Griffith D. E. Risk-benefit assessment of therapies for Mycobacterium avium complex infections. Drug Saf: 1999; 21 2 137 152 (Pubitemid 29389173)
77. Quittell L. M. Management of non-tuberculous mycobacteria in patients with cystic fibrosis. Paediatr Respir Rev: 2004; 5 (Suppl A): S217 S219
78. Hayes D. Jr. Mycobacterium abscessus and other nontuberculous mycobacteria: evolving respiratory pathogens in cystic fibrosis: a case report and review. South Med J: 2005; 98 6 657 661 (Pubitemid 40848106)
79. Gibson R. L., Burns J. L., Ramsey B. W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med: 2003; 168 8 918 951 (Pubitemid 37267172)
80. Griffith D. E., Aksamit T. R. Therapy of refractory nontuberculous mycobacterial lung disease. Curr Opin Infect Dis: 2012; 25 2 218 227
81. Huang Y. C., Liu M. F., Shen G. H., et al. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. J Microbiol Immunol Infect: 2010; 43 5 401 406
82. Döring G., Conway S. P., Heijerman H. G., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J: 2000; 16 4 749 767
83. Kearns G. L., Trang J. M. Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototype. J Pediatr: 1986; 108 5 Pt 2 847 853 (Pubitemid 16063285)
84. de Groot R., Smith A. L. Antibiotic pharmacokinetics in cystic fibrosis: differences and clinical significance. Clin Pharmacokinet: 1987; 13 4 228 253 (Pubitemid 17165720)
85. Rey E., Tréluyer J. M., Pons G. Drug disposition in cystic fibrosis. Clin Pharmacokinet: 1998; 35 4 313 329 (Pubitemid 28491216)
86. Reed M. D., Spino M. Clinical pharmacokinetics: concepts to practice. In: Orenstein D. M., Stern R. C., eds. Treatment of the Hospitalized Cystic Fibrosis Patient. New York, NY Marcel Dekker: 1998; 301 355
87. Gilljam M., Berning S. E., Peloquin C. A., Strandvik B., Larsson L. O. Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. Eur Respir J: 1999; 14 2 347 351 (Pubitemid 29461300)
88. Alcaide F., Calatayud L., Santín M., Martín R. Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii. Antimicrob Agents Chemother: 2004; 48 12 4562 4565 (Pubitemid 39577654)
89. Cavusoglu C., Soyler I., Akinci P. Activities of Linezolid against nontuberculous mycobacteria. New Microbiol: 2007; 30 4 411 414 (Pubitemid 350183839)
90. Brown-Elliott B. A., Crist C. J., Mann L. B., Wilson R. W., Wallace R. J. Jr. In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. Antimicrob Agents Chemother: 2003; 47 5 1736 1738 (Pubitemid 36548563)
91. Cremades R., Santos A., Rodríguez J. C., Garcia-Pachón E., Ruiz M., Royo G. Mycobacterium abscessus from respiratory isolates: activities of drug combinations. J Infect Chemother: 2009; 15 1 46 48
92. Cremades R., Santos A., Rodríguez J. C., Garcia-Pachon E., Ruiz M., Royo G. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae. J Chemother: 2008; 20 1 43 47 (Pubitemid 351428661)
93. Cholo M. C., Steel H. C., Fourie P. B., Germishuizen W. A., Anderson R. Clofazimine: current status and future prospects. J Antimicrob Chemother: 2012; 67 2 290 298
94. Rastogi N., Goh K. S., Bryskier A., Devallois A. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine. Antimicrob Agents Chemother: 1996; 40 11 2483 2487 (Pubitemid 26367629)
95. Levin R. H., Bolinger A. M. Treatment of nontuberculous mycobacterial infections in pediatric patients. Clin Pharm: 1988; 7 7 545 551
96. Shen G. H., Wu B. D., Hu S. T., Lin C. F., Wu K. M., Chen J. H. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria. Int J Antimicrob Agents: 2010; 35 4 400 404
97. van Ingen J., van der Laan T., Dekhuijzen R., Boeree M., van Soolingen D. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. Int J Antimicrob Agents: 2010; 35 2 169 173
98. da Silva Telles M. A., Chimara E., Ferrazoli L., Riley L. W. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates. J Med Microbiol: 2005; 54 Pt 10 975 979 (Pubitemid 41395856)
99. Davis K. K., Kao P. N., Jacobs S. S., Ruoss S. J. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulm Med: 2007; 7 2
100. Colin A. A. Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis. Pediatr Pulmonol: 2000; 30 3 267 268
101. Colin A. A., Ali-Dinar T. Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up. Pediatr Pulmonol: 2010; 45 6 626 627
102. Chbeir E., Casas L., Toubia N., Tawk M., Brown B. Adult cystic fibrosis presenting with recurrent non-tuberculous mycobacterial infections. Lancet: 2006; 367 9526 1952 (Pubitemid 43831999)
103. Oermann C. M., Starke J. R., Seilheimer D. K. Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis. Pediatr Infect Dis J: 1997; 16 2 257 259 (Pubitemid 27078804)
104. Kinney J. S., Little B. J., Yolken R. H., Rosenstein B. J. Mycobacterium avium complex in a patient with cystic fibrosis: disease vs. colonization. Pediatr Infect Dis J: 1989; 8 6 393 396 (Pubitemid 19157284)
105. Koh W. J., Kim Y. H., Kwon O. J., et al. Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria. J Korean Med Sci: 2008; 23 3 397 401
106. Nelson K. G., Griffith D. E., Brown B. A., Wallace R. J. Jr. Results of operation in Mycobacterium avium-intracellulare lung disease. Ann Thorac Surg: 1998; 66 2 325 330 (Pubitemid 28410654)
107. Yu J. A., Pomerantz M., Bishop A., Weyant M. J., Mitchell J. D. Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease. Eur J Cardiothorac Surg: 2011; 40 3 671 675
108. Mitchell J. D., Bishop A., Cafaro A., Weyant M. J., Pomerantz M. Anatomic lung resection for nontuberculous mycobacterial disease. Ann Thorac Surg: 2008; 85 6 1887 1892, discussion 1892-1893
109. Lucas J., Connett G. J., Lea R., Rolles C. J., Warner J. O. Lung resection in cystic fibrosis patients with localised pulmonary disease. Arch Dis Child: 1996; 74 5 449 451 (Pubitemid 26170045)
110. Steinkamp G., von der Hardt H., Zimmermann H. J. Pulmonary resection for localized bronchiectasis in cystic fibrosis. Report of three cases and review of the literature. Acta Paediatr Scand: 1988; 77 4 569 575
111. Marmon L., Schidlow D., Palmer J., Balsara R. K., Dunn J. M. Pulmonary resection for complications of cystic fibrosis. J Pediatr Surg: 1983; 18 6 811 815 (Pubitemid 14175278)
112. Camargos P., Le Bourgeois M., Revillon Y., et al. Lung resection in cystic fibrosis: a survival analysis. Pediatr Pulmonol: 2008; 43 1 72 76
113. Levitsky S., Lapey A., Di Sant-Agnese P. A. Pulmonary resection for life-threatening hemoptysis in cystic fibrosis. JAMA: 1970; 213 1 125 127
114. Smith M. B., Hardin W. D. Jr, Dressel D. A., Beckerman R. C., Moynihan P. C. Predicting outcome following pulmonary resection in cystic fibrosis patients. J Pediatr Surg: 1991; 26 6 655 659
115. Weiss E. S., Allen J. G., Merlo C. A., Conte J. V., Shah A. S. Factors indicative of long-term survival after lung transplantation: a review of 836 10-year survivors. J Heart Lung Transplant: 2010; 29 3 240 246
116. Christie J. D., Edwards L. B., Kucheryavaya A. Y., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant: 2010; 29 10 1104 1118
117. Chalermskulrat W., Sood N., Neuringer I. P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax: 2006; 61 6 507 513 (Pubitemid 43901521)
118. Kesten S., Chaparro C. Mycobacterial infections in lung transplant recipients. Chest: 1999; 115 3 741 745 (Pubitemid 29129955)
119. Malouf M. A., Glanville A. R. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med: 1999; 160 5 Pt 1 1611 1616
120. Bonvillain R. W., Valentine V. G., Lombard G., LaPlace S., Dhillon G., Wang G. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. J Heart Lung Transplant: 2007; 26 9 890 897 (Pubitemid 47369203)
121. Knoll B. M., Kappagoda S., Gill R. R. et al. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis: 2012; 14 5 452 460
122. Flume P. A., Egan T. M., Paradowski L. J., Detterbeck F. C., Thompson J. T., Yankaskas J. R. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med: 1994; 149 6 1601 1607 (Pubitemid 24175982)
123. Sanguinetti M., Ardito F., Fiscarelli E., et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol: 2001; 39 2 816 819 (Pubitemid 32150872)
124. Taylor J. L., Palmer S. M. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant: 2006; 25 8 985 988 (Pubitemid 44143007)
125. Gilljam M., Scherstén H., Silverborn M., Jönsson B., Ericsson Hollsing A. Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. J Cyst Fibros: 2010; 9 4 272 276
126. Zaidi S., Elidemir O., Heinle J. S., et al. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl Infect Dis: 2009; 11 3 243 248
127. Morales P., Gil A., Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc: 2010; 42 8 3058 3060
128. Watkins R. R., Lemonovich T. L. Evaluation of infections in the lung transplant patient. Curr Opin Infect Dis: 2012; 25 2 193 198
129. Luong M. L., Morrissey O., Husain S. Assessment of infection risks prior to lung transplantation. Curr Opin Infect Dis: 2010; 23 6 578 583
130. Chernenko S. M., Humar A., Hutcheon M., et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant: 2006; 25 12 1447 1455 (Pubitemid 44909461)